Table 3.
Sera | Acute infecting pathogen | Ab bott IgG | FRENDTM IgG | Ro che total antibodies | Snibe IgG | Beckman IgG | Mind ray IgG |
Mind ray total antibodies | Sie mens total antibodies | Vazyme sVNT | Gen Script sVNT |
---|---|---|---|---|---|---|---|---|---|---|---|
#1 (<2016)1 | R typhi | Neg | Neg | Neg | 3.2 | Neg | Neg | Neg | Neg | Neg | Neg |
#2 (<2016)2 | Influenza B | Neg | Neg | Neg | 3.1 | Neg | Neg | Neg | Neg | Neg | Neg |
#3 (<2016)3 | UNK | Neg | Neg | Neg | 3.3 | Neg | Neg | Neg | Neg | Neg | Neg |
#4 (<2016)3 | R typhi | Neg | Neg | 2.6 | 2.7 | Neg | Neg | Neg | Neg | Neg | Neg |
#5 (<2016)3 | UNK | Neg | 16.4 | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg |
#6 (<2016)3 | Leptospira spp | Neg | Neg | Neg | Neg | Neg | Neg | Neg | 1.43 | Neg | Neg |
#7 (<2016)3 | Influenza B | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg | 41.9 | 47.4 |
#8 (2020) | UNK | Neg | Neg | Neg | Neg | Neg | Neg | 15.9 | Neg | Neg | Neg |
#9 (2020) | UNK | Neg | Neg | Neg | 3.2 | Neg | Neg | Neg | Neg | Neg | Neg |
#10 (2020) | UNK | Neg | Neg | 1.75 | Neg | Neg | Neg | Neg | Neg | Neg | Neg |
#11 (2020) | UNK | Neg | Neg | Neg | Neg | Neg | Neg | 27.9 | Neg | Neg | Neg |
#12 (2020) | UNK | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg | 27.8 | Neg |
#13 (2020) | UNK | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg | 20.1 | Neg |
#14 (2020) | UNK | 2.1 | 46.6 | Neg | Neg | Neg | Neg | Neg | Neg | Neg | Neg |
There were also 47 sera with IgG antibodies to dengue, 25 with IgG abs to Leptospira spp and 24 with IgG antibodies of murine typhus but remained negative for SARS-CoV-2 antibodies to any assay.
Serum also contained IgG to dengue and chikungunya viruses, and Salmonella typhi.
Serum also contained IgG to dengue and chikungunya viruses, Salmonella typhi and Leptospira spp.
Serum also contained IgG to dengue virus.